AIM: To explore the expression pattern of E2F5 in primary hepatocellular carcinomas (HCCs) and elucidate the roles of E2F5 in hepatocarcinogenesis. METHODS: E2F5 expression was analyzed in 120 primary HCCs and 29 normal liver tissues by immunohistochemistry analysis. E2F5-small interfering RNA was transfected into HepG2, an E2F5-overexpressed HCC cell line. After E2F5 knockdown, cell growth capacity and migrating potential were examined. RESULTS: E2F5 was significantly overexpressed in primary HCCs compared with normal liver tissues (P = 0.008). The E2F5-silenced cells showed significantly reduced proliferation (P = 0.004). On the colony formation and soft agar assays, the number of colonies was significantly reduced in E2F5-silenced cells (P = 0.004 and P = 0.009, respectively). E2F5 knockdown resulted in the accumulation of G0/G1 phase cells and a reduction of S phase cells. The number of migrating/invading cells was also reduced after E2F5 knockdown (P = 0.021). CONCLUSION: To our knowledge, this is the first evidence that E2F5 is commonly overexpressed in primary HCC and that E2F5 knockdown significantly repressed the growth of HCC cells.
AIM: To explore the expression pattern of E2F5 in primary hepatocellular carcinomas (HCCs) and elucidate the roles of E2F5 in hepatocarcinogenesis. METHODS:E2F5 expression was analyzed in 120 primary HCCs and 29 normal liver tissues by immunohistochemistry analysis. E2F5-small interfering RNA was transfected into HepG2, an E2F5-overexpressed HCC cell line. After E2F5 knockdown, cell growth capacity and migrating potential were examined. RESULTS:E2F5 was significantly overexpressed in primary HCCs compared with normal liver tissues (P = 0.008). The E2F5-silenced cells showed significantly reduced proliferation (P = 0.004). On the colony formation and soft agar assays, the number of colonies was significantly reduced in E2F5-silenced cells (P = 0.004 and P = 0.009, respectively). E2F5 knockdown resulted in the accumulation of G0/G1 phase cells and a reduction of S phase cells. The number of migrating/invading cells was also reduced after E2F5 knockdown (P = 0.021). CONCLUSION: To our knowledge, this is the first evidence that E2F5 is commonly overexpressed in primary HCC and that E2F5 knockdown significantly repressed the growth of HCC cells.
Entities:
Keywords:
E2F family; E2F5; Hepatocellular carcinoma; Oncogene; Small interfering RNA
Authors: Eunice Y Lee; Hieu Cam; Ulrike Ziebold; Joseph B Rayman; Jacqueline A Lees; Brian David Dynlacht Journal: Cancer Cell Date: 2002-12 Impact factor: 31.743
Authors: V Shridhar; J Lee; A Pandita; S Iturria; R Avula; J Staub; M Morrissey; E Calhoun; A Sen; K Kalli; G Keeney; P Roche; W Cliby; K Lu; R Schmandt; G B Mills; R C Bast; C D James; F J Couch; L C Hartmann; J Lillie; D I Smith Journal: Cancer Res Date: 2001-08-01 Impact factor: 12.701
Authors: J Polanowska; L Le Cam; B Orsetti; H Vallés; E Fabbrizio; L Fajas; S Taviaux; C Theillet; C Sardet Journal: Genes Chromosomes Cancer Date: 2000-05 Impact factor: 5.006
Authors: Bing Ren; Hieu Cam; Yasuhiko Takahashi; Thomas Volkert; Jolyon Terragni; Richard A Young; Brian David Dynlacht Journal: Genes Dev Date: 2002-01-15 Impact factor: 11.361
Authors: G Peter Sawiris; Cheryl A Sherman-Baust; Kevin G Becker; Chris Cheadle; Diane Teichberg; Patrice J Morin Journal: Cancer Res Date: 2002-05-15 Impact factor: 12.701
Authors: Narasimhan Kothandaraman; Vladimir B Bajic; Pang N K Brendan; Chan Y Huak; Peh B Keow; Khalil Razvi; Manuel Salto-Tellez; Mahesh Choolani Journal: BMC Cancer Date: 2010-02-24 Impact factor: 4.430
Authors: Bhavneet Bhinder; Christophe Antczak; Christina N Ramirez; David Shum; Nancy Liu-Sullivan; Constantin Radu; Mark G Frattini; Hakim Djaballah Journal: Assay Drug Dev Technol Date: 2012-11-30 Impact factor: 1.738